红细胞同工酶ADA－EAP一AK_1同步电泳分型方法的建立

综合、改良了分别分型的方法，建立了红细胞同工酶ＡＤＡ一ＥＡＰ一ＡＫ１同步电泳分型方法，为ＡＤＡ，ＥＡＰ和ＡＫ１３种红细胞同工酶在法医学鉴定中更广泛的应用，提供了一种可靠、经济、实用的方法。     

运动性疲劳中医肾虚证的辨证分型及其诊断标准

目的：阐明运动性疲劳中医肾虚证的主要证候及辨证标准。 方法：于2003-07／2004-01选择湖南省水上运动训练基地的皮划赛艇运动员和省体工大队的田径运动员共199名为研究对象。将中医辨证理论方法与流行病学调研疗法有机结合，统一诊断标准和资料处理方法，分析肾虚各证候构成比，进行聚类分析，观察单一症状出现频次、症状组合出现频次。 结果：纳入受试对象199名，均进入结果分析。①肾虚常见证候有腰脊酸痛，头晕目眩，精神疲倦，四肢乏力，胫膝酸软，气短自汗，五心烦热，口干少津，畏寒肢冷，小便清长，夜尿频多，少寐多梦。②肾虚各证候构成比：肾气虚（51．26％）、肾阴阳两虚（37.69％）、肾阳虚（6.53％）、肾阴虚（4．52％）。③聚类分析：第一类为腰脊酸痛，精神疲倦，四肢乏力，气短自汗；第二类为头晕目眩，胫膝酸软，畏寒肢冷，小便清长，夜尿频多；第三类为五心烦热，口干少津；第四类为少寐多梦。④参与组合频次大于50％的症状主要是：精神疲倦、四肢乏力、腰脊酸痛、头晕目眩、气短，这5个症状也是单个症状频次大于80％的。 结论：运动性疲劳中医肾虚证的常见证候为肾气虚、肾阴阳两虚、肾阳虚、肾阴虚。而肾气虚是运：动性疲劳中医肾虚的主要证候。精神疲倦、四肢乏力、腰脊酸痛、头晕目眩、气短这5个症状可以作为运动性疲劳肾气虚辨证标准中的主要症状。     

大鼠鼻咽癌变过程中全血硒和谷胱甘肽过氧化物酶的变化

作者观察了在二亚硝基哌嗪(DNP)诱发大鼠鼻咽癌变过程中全血硒浓度和谷胱甘肽过氧化物酶(GSH-PX)活性的变化及硒的作用。实验分5组:①空白对照组(BG);②硒对照组(SG);③DNP对照组(DG);④硒预防组(PG);⑤硒治疗组(TG)。结果显示,于饮水中补硒能提高大鼠血硒浓度和GSH-PX活性,而且能预防鼻咽癌的发生;在实验早期,各给致癌物组酶活性与相应的对照组无差异,后期前者均明显低于后者,且DG血硒浓度明显低于BG,说明肿瘤的形成引起了血中GSH-Px和硒浓度的降低;然而PG和TG血硒与SG无差异,说明血硒浓度的高低易受摄取量的影响,提示在评估肿瘤时,血GSH-PX活性也许比血硒更有用。经分析,大鼠全血GSH-PX活性与硒浓度之间有正相关关系(r=0.61,P相似文献   

肝炎和肝硬化患者胆囊超声改变的观察与分析

目的 :研究肝炎肝硬化患者胆囊彩色B超声像图变化 ,并探讨其临床意义。方法 :采用彩色超声诊断仪对 139例肝炎和肝硬化患者及 4 2例非肝炎体检者进行胆囊超声检查。结果 :慢性肝炎、重型肝炎、肝硬化患者组与非肝炎对照组彩色B超胆囊异常率比较均差异显著 (P <0 .0 1)。重型肝炎、肝硬化组与慢性肝炎组之间胆囊异常率也存在明显的差异 (P <0 .0 5 )。结论 :慢性肝病患者胆囊异常与胆囊本身炎症无关。胆囊声像图的改变对判断肝脏实质性病变的严重程度及指导临床治疗有一定的参考价值。     

中效人胰岛素联合瑞格列奈治疗磺脲类降糖药继发性失效临床观察

目的观察中效人胰岛素与瑞格列奈联合应用治疗磺脲类降糖药继发性失效的疗效。方法将磺脲类降糖药继发性失效(SFS)36例病例随机分成两组,分别接受睡前小剂量中效人胰岛素加瑞格列奈(A组,20例)和单纯瑞格列奈(B组,16例)治疗,比较两组各生化指标。结果①治疗前空腹血糖(FPG)、餐后2小时血糖(2hPG)、C肽(C-P)、糖化血红蛋白(HbA1c)水平两组间无统计学差异;②治疗3个月后两组自身的FPG、2hPG、C-P、HbA1c水平均较治疗前明显改善,P值分别为0.01、0.05、0.05、0.01;③治疗3个月后FPG、2hPG、C-P、HbA1c水平A组均低于B组,P值分别<0.01、0.05、0.05、0.01。结论中效人胰岛素联合瑞格列奈和单用瑞格列奈治疗磺脲类降糖药继发性失效均有疗效,胰岛素和瑞格列奈联用优于单用瑞格列奈。     

Cloning of Human α-defensin-1 (HNP-1) Gene and Construction of Its Eukaryotic Expression Vector

1 Introduction Defensins are small cationic antimicrobial peptides that function in the host's innate immune system. The human defensin family includes three small peptides from the azurophil granules of polymorphonuclear cells named human neutrophil peptide (HNP)-1, HNP-2, HNP-3,which consist 5%-7% of the protein of human neutrophil. HNP-4 is approximately one hundred times less abundant. They demonstrate antibacterial, antifungal and antiviral properties in vitro. HNPs are important component of nonoxidative mechanism in macrophages, and can direct inactivate the enveloped viruses. Because only special cells express defensins. And it is hard to extract them naturally and the production is few. So researcher expect to obtain defensins highly through heterogenous expression by gene engineering technology. In order to express HNP-1, we cloned the cDNA of HNP-1 from human polymorphonuclear cells in peripheral blood, and constructed its eukaryotic expression vector, which provided a base for the further study on its mechanism of antimicrobial effect.     

移植于脊髓的断离肋间神经重发新支至原去神经肋间肌的实验观察

将15只大鼠左侧第11或12肋间神经从根部向外,自周围组织完全分离出20～35mm,并于此处剪断。再将其近端改向植入脊髓左侧半 L_(1～2) 之间的髓节内。在存活57～413天后解剖观察,发现自移植神经的干上发出1～3条新分支,分布于原去神经的肋间肌。经光、电镜观察证实是成活的再生神经纤维。于移植神经干注射 CB-HRP 后,发现这些神经纤维来源于原肋间神经髓节的前角和移植部髓节内的神经细胞。故认为外周神经缺损,不作神经对接或桥接,不经断离神经的远段,在一定条件下可以由近段发出再生纤维组成新支,分布于去神经的靶组织。     

香萱解郁方对血清剥夺诱导HT22细胞损伤模型的神经保护作用

探讨香萱解郁方含药血清对血清剥夺致小鼠海马神经元HT22细胞损伤模型的影响。方法 采用血清剥夺培养HT22细胞建立神经损伤体外模型,实验分为对照组、模型组和中药组［中药组A（含药血清15%浓度）、中药组B（含药血清20%浓度）］,各组血清剥夺12 h后,通过CCK8法检测各组细胞活力,确定15%浓度含药血清干预后细胞的存活率最高,设定为后续实验中药组的药物浓度。免疫荧光染色法检测神经元特异性微管蛋白（β-Tubulin Ⅲ）在各组中的表达,蛋白质免疫印迹法及qPCR法检测脑源性神经营养因子（BDNF）蛋白及其mRNA在各组中的表达。结果 在加药后培养12 h,中药组的细胞活力明显高于对照组与模型组（P＜0.001）。培养24 h,模型组细胞活力较对照组明显下降（P＜0.001）,中药组较模型组明显提高（P＜0.001）。培养36 h,模型组细胞活力较对照组显著下降（P＜0.001）,中药组较模型组明显提高（P＜0.001）。模型组BDNF蛋白含量及 BDNF mRNA表达量较对照组显著降低（P＜0.05,P＜0.001）,模型组少数神经元长出突起;中药组BDNF蛋白含量及BDNF mRNA表达量较模型组显著增加（P＜0.05）,中药组HT22细胞轴突突起长度和分支增加,β-Tubulin Ⅲ阳性表达明显增多。结论 香萱解郁方含药血清对血清剥夺诱导小鼠海马神经元HT22细胞损伤具有神经保护作用,可能与促进BDNF蛋白表达有关     

The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence

We studied the autoantigen targets of 75 human sera that had antibodies to the nuclear envelope (NE) as identified by indirect immunofluorescence (IIF) on HEp‐2 cells. Several different IIF staining patterns could be identified when antibodies to different components of the nuclear membrane (NM) and nuclear pore complexes (NuPC) were identified: a smooth membrane pattern characteristic of antibodies to nuclear lamins, a punctate pattern typical of antibodies to the nuclear pore complex and more complex patterns that included antibodies to nuclear and cytoplasmic organelles. Western immunoblotting of isolated nuclear and NE proteins and immunoprecipitation of radiolabelled recombinant proteins prepared by using the full‐length cDNAs of the Translocated promoter region (Tpr), gp210 and p62 were used to identify specific autoantibody targets. Fifty‐two of the 75 (70%) sera bound to Tpr, 25 (33%) bound to lamins A, B or C, 15 (20%) reacted with gp210 and none reacted with p62. Sixteen (21%) did not react with any of the NE components tested in our assays. The clinical features of 37 patients with anti‐NE showed that there were 34 females and three males with an age range of 16–88 years (mean 59 years). The most frequent clinical diagnosis (9/37 = 24%) was autoimmune liver disease (ALD; two with primary biliary cirrhosis), followed by seven (19%) with systemic lupus erythematosus (SLE), four (11%) with a motor and/or sensory neuropathy, three (8%) with anti‐phospholipid syndrome (APS), two with systemic sclerosis (SSc), two with Sjögren's syndrome (SjS), and others with a variety of diagnoses. This report indicates that Tpr, a component of the NuPC, is a common target of human autoantibodies that react with the NE.